FDA clears novel generic thyroid cancer treatment
FDA cleared the first generic sodium iodide product in the U.S. to treat hyperthyroidism and carcinoma of the thyroid.
Read more
 
Small molecular drugs led 2019 approvals
FDA’s Center for Drug Evaluation and Research approved fewer new treatments in 2019.
Read more
 
EDITOR'S PICK
Sarcoma med will be available soon
Novel cancer drug snags FDA approval.
Read more